Search Results - Lekkala, Ramamohan

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract 1701: EPL-1410, a novel fused heterocycle based orally active dual inhibitor of IDO1/TDO2, as a potential immune-oncology therapeutic

    Abstract 1701: EPL-1410, a novel fused heterocycle based orally active dual inhibitor of IDO1/TDO2, as a potential immune-oncology therapeutic by Gullapalli, Srinivas, Roychowdhury, Abhijit, Khaladkar, Tushar, Sawargave, Sangameshaver, Janrao, Ravindra, Kalhapure, Vijay, Urunkar, Ganesh, Kulathingal, Jayanarayan, Lekkala, Ramamohan Reddy, Bhadra, Sonali, Singh, Pankaj Kumar, Putta, Krishna Anand, Manwatkar, Sonali, Surve, Prashant, Gurjar, Mukund Keshav

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 1729: KL-ON113, a novel orally available dual EGFR kinase inhibitor targeting EGFR-activating and T790M mutants

    Abstract 1729: KL-ON113, a novel orally available dual EGFR kinase inhibitor targeting EGFR-activating and T790M mutants by Lakshmikanthan, Vijaybaskar, Sommepalli, Venkateswarlu, Lekkala, Ramamohan, Rasamsetti, Kondababu, Gokaraju, Rama Raju, Bhupathiraju, Kiran, Kasina, Sudhakar

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: